|
After-Not valuable (<3)
|
8
|
1
|
0
|
9
|
|
After-Neutral (3)
|
10
|
20
|
3
|
33
|
|
After-Valuable(>3)
|
2
|
18
|
12
|
32
|
| |
20
|
39
|
15
| |
|
In your opinion, what is the educational value to medical students offered by detailing from pharmaceutical representatives? (1 = No value at all, 5 = Extremely valuable)
|
| |
Before-Not Valuable (<3)
|
Before-Neutral (3)
|
Before-Valuable (>3)
| |
|
After-Not valuable (<3)
|
13
|
0
|
0
|
13
|
|
After-Neutral (3)
|
8
|
19
|
4
|
31
|
|
After-Valuable(>3)
|
6
|
10
|
14
|
30
|
| |
27
|
29
|
18
| |
|
What is you perception of the degree of bias in the information provided by pharmaceutical representatives detailing to practicing physicians? (1 = Not at all biased, 5 = Totally biased)
|
| |
Before-Not Biased (<3)
|
Before-Neutral (3)
|
Before-Biased (>3)
| |
|
After-Not biased (<3)
|
0
|
1
|
1
|
2
|
|
After-Neutral (3)
|
0
|
6
|
12
|
18
|
|
After-Biased(>3)
|
0
|
3
|
51
|
54
|
| |
0
|
10
|
64
| |
|
How influential are pharmaceutical representatives with regard to physicians' prescribing habits? (1 = Not at all influential, 5 = Very influential)
|
| |
Before-Not Influential (<3)
|
Before-Neutral (3)
|
Before-Influential (>3)
| |
|
After-Not influential (<3)
|
2
|
2
|
1
|
5
|
|
After-Neutral (3)
|
7
|
11
|
5
|
23
|
|
After- Influential (>3)
|
2
|
17
|
27
|
36
|
| |
11
|
30
|
33
| |
